Clinical Trial Update: Matrix Metalloproteinases After Surgery and/or Radiofrequency Ablation in Patients With Liver Metastases From Colorectal Cancer

View source ↗

Summary

The study evaluating matrix metalloproteinases after surgery and/or radiofrequency ablation in patients with colorectal cancer liver metastases has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: University Hospital, Grenoble | Conditions: Colorectal Cancer, Metastatic Cancer | Status: COMPLETED